Diabetes Care:空气污染诱发糖尿病患者炎症反应

2013-03-04 晓东 整理 医学论坛网

  《糖尿病护理》杂志日前发表伊朗和印度科学家合作完成的一项新研究[Diabetes Care. 2013 Mar;36(3):625-30]称,空气污染可能诱发2型糖尿病患者全身性炎症反应,增加其发生血管并发症的风险。   血浆C-反应蛋白(CRP)水平与胰岛素抵抗、糖尿病及其并发症呈现相关性,血浆CRP水平下降有助于降低胰岛素抵抗、糖尿病并发症发生风险。伊朗让迪

  《糖尿病护理》杂志日前发表伊朗和印度科学家合作完成的一项新研究[Diabetes Care. 2013 Mar;36(3):625-30]称,空气污染可能诱发2型糖尿病患者全身性炎症反应,增加其发生血管并发症的风险。

  血浆C-反应蛋白(CRP)水平与胰岛素抵抗、糖尿病及其并发症呈现相关性,血浆CRP水平下降有助于降低胰岛素抵抗、糖尿病并发症发生风险。伊朗让迪·夏普尔医科大学和印度浦那大学科学家对印度浦那上千名2型糖尿病患者进行了对比研究。研究人员将每日空气污染数据与参试者的C-反应蛋白血浆浓度进行了相关性评估分析。并且,在采集血样前30天,研究人员还对参试者体质指数、糖化血红蛋白水平、空腹血糖值、抗炎活性药物治疗方案、周围气温和相对湿度等因素进行了校正。

  研究结果显示,多日平均二氧化硫(最长30天)和一氧化氮(最长7天)浓度的升高与CRP血浆浓度升高存在显著相关性。在新确诊糖尿病患者和没有服用他汀和噻唑烷二酮的糖尿病患者中,空气污染与CRP血浆浓度之间的正相关性最为显著。

  研究负责人莫尔塔扎·A·卡法伊博士表示,这项新研究首次表明,空气污染在2型糖尿病全身性炎症反应中起到一定的作用。新研究建议,糖尿病患者在空气污染的时候,要增加复诊的几率,重视遵医嘱调药,减少外出,同时增加室内活动的机会,保持抵抗力。

空气污染相关的拓展阅读:


OBJECTIVE 
To study the association between ambient air pollutants and serum C-reactive protein (CRP) concentration in 1,392 type 2 diabetic patients in Pune, India.
RESEARCH DESIGN AND METHODS 
A cross-sectional study was conducted that linked daily time series of ambient air pollution data (obtained from central monitoring sites) and plasma CRP concentration in type 2 diabetic patients from the Wellcome Trust Genetic (WellGen) Study, recruited between March 2005 and May 2007. Air pollution effects on CRP concentration were investigated with delays (lags) of 0–7 days and multiday averaging spans of 7, 14, and 30 days before blood collection adjusted for age, sex, BMI, hemoglobin, fasting plasma glucose, treatment with agents with anti-inflammatory action, season, air temperature, and relative humidity.
RESULTS 
Median CRP concentration was 3.49 mg/L. For 1 SD increase in SO2 and oxides of nitrogen (NOx) concentrations in ambient air, a day before blood collection (lag1), we observed a significant increase in CRP (9.34 and 7.77%, respectively). The effect was higher with lag2 (12.42% for SO2 and 11.60% for NOx) and wore off progressively thereafter. We also found a significant association with multiday averaging times of up to 30 and 7 days for SO2 and NOx, respectively. No significant associations were found between particulate matter with an aerodynamic profile ≤10 µm (PM10) and CRP concentration except in summer. The association was significantly higher among patients with a shorter duration of diabetes, and in those not on statin and thiazolidinedione treatment.
CONCLUSIONS 
We demonstrate, for the first time, a possible contribution of ambient air pollution to systemic inflammation in Indian type 2 diabetic patients. This may have implications for vascular complications of diabetes.

    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1636629, encodeId=44451636629ef, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Apr 10 07:35:00 CST 2013, time=2013-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901053, encodeId=c132190105372, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Dec 13 19:35:00 CST 2013, time=2013-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759246, encodeId=a35e1e59246e8, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 26 19:35:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320799, encodeId=49cb1320e99fc, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472411, encodeId=b1ee14e2411bb, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473688, encodeId=cb4314e368820, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Mar 06 00:35:00 CST 2013, time=2013-03-06, status=1, ipAttribution=)]

相关资讯

Diabetes Care:LOGIC-Insulin算法指导强化血糖控制效果佳

  来自荷兰鲁汶大学的一项前瞻性、平行组、随机对照临床试验显示,应用计算机软件程序LOGIC-Insulin实施强化血糖控制(TGC)的效能优于经验丰富的护士,且不增加低血糖事件的发生率。该研究2013年2月在线发表在《糖尿病护理》杂志(Diabetes care)上。   对危重患者实施TGC较为困难,且工作强度大,导致血糖控制效果不佳和低血糖发生率增加。LOGIC-Insul

Diabetes Care:经皮氧分压可预测糖尿病患者心血管风险

  意大利学者进行的一项研究提示,经皮氧分压(TcPO2)是无合并症2型糖尿病患者主要不良心脏事件(MACE)风险的潜在预测指标,且预测价值似乎高于踝臂指数(ABI)。研究于2013年2月12日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究入选361例无合并症的2型糖尿病患者,随访45.8个月期间共发生67例MACE。研究者报告,发生MACE的受试者中ABI(≤0.9)

JGIM:血糖达标非糖尿病患者心血管获益关键

  一项纳入2.6万余例受试者的观察性研究显示,对于2型糖尿病患者,收缩压(SBP,<130 mm Hg)或低密度脂蛋白胆固醇(LDL-C,<100 mg/dl)达标与心血管疾病(CVD)住院风险的降低显著相关,而糖化血红蛋白(HbA1c)达标(<7%)并不是CVD住院风险降低的独立因素。(J Gen Intern Me

PLOS ONE:强化降糖或使肥胖糖尿病患者获益

  一项覆盖9项随机对照研究、59 197例受试者的Meta分析提示,对于体质指数(BMI)>30 kg/m2的糖尿病患者,与标准降糖方案相比,强化降糖方案可有效降低卒中发生风险。(PLoS One. 2013,8:e54465)   在被纳入的59 197例受试者中,2037例罹患卒中。分析结果显示,在整个受试人群中,与标准降糖方案相比,

Diabetes Care:美国糖尿病患者“三达标率”较高

  美国学者Sarah Stark Casagrande等报告,2007-2010年间有18.8%的美国糖尿病患者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDL-C)水平同时达标,达标率是我国糖尿病患者(5.6%)的3倍以上。研究于2013年2月15日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究者利用1988-2010年美国国

JAMA Intern Med:普通健康体检未能降低死亡率

  丹麦学者的一项荟萃分析综述表明,普通健康体检未能降低总体死亡率。该综述1月14日在线发表于《JAMA内科学》(JAMA Intern Med)。   此项荟萃分析共纳入14项于1963至1999年间实施的随机对照试验,并评估了年度体检对发病率和死亡率的影响。以仅用于预防咨询和筛查的就诊定义普通体检,排除慢性病治疗或紧急救护所引发的就诊。纳入试验共涉及182,000余例患者